Figure 4.
Risk of infection. Risk of infection (CTCAE grade ≥2) from end of cycle 15 for arm A (ibrutinib maintenance), arm B (treatment cessation), and nonrandomized patients continuing ibrutinib. CTCAE, common terminology criteria for AEs.

Risk of infection. Risk of infection (CTCAE grade ≥2) from end of cycle 15 for arm A (ibrutinib maintenance), arm B (treatment cessation), and nonrandomized patients continuing ibrutinib. CTCAE, common terminology criteria for AEs.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal